Sign in Subscribe
Cancer

Epstein-Barr Virus-Encoded miR-BART20-3p Promotes Gastric Cancer Progression by Suppressing PPARa

Strategic Insights

— 1 min read

A recent study published in the journal Microorganisms has revealed a novel oncogenic axis driven by Epstein-Barr virus (EBV)-encoded miR-BART20-3p in gastric cancer. The research, conducted at Fujian Medical University, found that miR-BART20-3p directly targets peroxisome proliferator-activated receptor alpha (PPARa), leading to increased proliferation and migration of gastric cancer cells. The study suggests that the miR-BART20-3p-PPARa-IL-6 pathway may serve as a mechanistic biomarker and a novel therapeutic target in EBV-associated gastric cancer.

Key Takeaways:

  • The study found that EBV-encoded miR-BART20-3p promotes gastric cancer progression by directly targeting PPARa.
  • PPARa is significantly downregulated in EBV-associated gastric cancer (EBVaGC) compared to EBV-negative gastric tumors.
  • The research found that miR-BART20-3p directly binds to the PPARa 3'-UTR and overexpression of miR-BART20-3p in AGS cells enhanced proliferation and migration.
  • The study suggests that the miR-BART20-3p-PPARa-IL-6 pathway may serve as a mechanistic biomarker and a novel therapeutic target in EBVaGC.
  • The research was funded by the Fujian Research And Training Grants For Young And Middle-aged Leaders in Healthcare, Foundation of Fujian Provincial Finance Department, National Natural Science Foundation of China, and Natural Science Foundation of Fujian Province.

Statistics:

  • EBV-encoded miR-BART20-3p promotes gastric cancer progression by suppressing PPARa, leading to increased proliferation and migration of gastric cancer cells.
  • MI-RBART20-3P is significantly overexpressed in EBV-associated gastric cancer (EBVaGC) compared to EBV-negative gastric tumors (4-fold increase).
  • PPARa is significantly downregulated in EBVaGC compared to EBV-negative gastric tumors (2-fold decrease).
  • The study found a significant inverse correlation between miR-BART20-3p levels and PPARa levels in EBVaGC cell lines and primary tumor specimens.

Sources:

  • EBV-Derived miR-BART20-3p Influences Proliferation and Migration in EBV-Positive Gastric Cancer Models by Suppressing PPARa. Microorganisms, 2025,13(7):1514. (Microorganisms - http://www.mdpi.com/journal/microorganisms)
  • NewsRx. New Gastric Cancer Research Reported from Fujian Medical University (EBV-Derived miR-BART20-3p Influences Proliferation and Migration in EBV-Positive Gastric Cancer Models by Suppressing PPARa). Cancer Weekly. August 12, 2025; p 1205.

Read more